Sanofi

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

French pharma giant Sanofi appointed Paul Hudson as chief executive to replace Olivier Brandicourt, who will retire in September, the company said on Friday.

Sanofi appoints Paul Hudson as CEO to replace retiring Brandicourt

Amgen

AstraZeneca

Bristol-Myers

Merck

Novartis

Roche Holding AG

The annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago sees cancer data presentations from several drug/biotech companies about the latest developments in treating cancer.

Was ASCO Quieter for Big Drug/Biotech Stocks This Year?

Alnylam Pharmaceuticals

Bayer AG

BioMarin Pharmaceutical

BioMarin (BMRN) announces significant reduction in annual bleed rate in phase III study evaluating gene therapy, valoctocogene roxaparvovec, in hemophilia A patients. However, investors are skeptical.

BioMarin Announces Data on Hemophilia Candidate, Shares Fall

Sanofi is a pharma company putting in very consistent performances.

Sanofi: A Robust Pharma Giant With Strong Growth In Q1

Apple

Activision Blizzard

Alphabet

Microsoft

Tencent Holdings Limited

If you're looking to invest in the growing popularity of video games, you might want to start by considering these sector winners.

These 6 Giants Control Half the Global Video Game Market

Amarin Corporation Plc

Cellectar BioSciences

GW Pharmaceuticals

The biotechnology space is an exciting one with incredible potential for investors.

5 Biotech Stocks With Near-Term Catalysts Ahead

Sanofi S.A. (SNY) CEO Olivier Brandicourt on Q1 2019 Results - Earnings Call Transcript

Sanofi's first-quarter 2019 results were mixed as it beat estimates for earnings but missed the same for sales.

Sanofi (SNY) Q1 Earnings Top, Genzyme & Vaccines Drive Sales

The move is a pre-emptive one as the French drugmaker is set to testify before the House Energy and Commerce Committee on the rising prices of insulin later in the day.

Sanofi sets a fixed price of insulin at $99 per month for some patients

Shares of French pharmaceutical giant Sanofi dipped Friday after the FDA rejected its application for a diabetes treatment created under a partnership with Lexicon Pharmaceuticals.

This Pharma Giant Slipped After FDA Rejected Its Diabetes Treatment

Jazz Pharmaceuticals

Ligand Pharmaceuticals

Leap Therapeutics

Lexicon Pharmaceuticals

PhaseBio Pharmaceuticals Inc

SAGE Therapeutics

Strongbridge Biopharma

Biotech stocks had an upweek, with the release of clinical trial results and the positive broader market sentiment offering ample support.

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings

News for Sanofi Stock (SNY)